Dan Dischner | Vice President of Human Resources and Corporate Communications |
Bill Peters | Chief Financial Officer |
Tony Marrs | Senior Vice President of Regulatory Affairs and Clinical Operations |
Tim Chiang | Northland Capital Markets |
David Amsellem | Piper Sandler |
Rafay Sardar | BMO Capital Markets |
David Steinberg | Jefferies |
Tian Sun | Needham & Company |
Welcome to the Amphastar's second quarter earnings call. My name is Anna, and I will be your operator for today's call. [Operator Instructions] All statements in the conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectations regarding future financial performance; backlog; sales and marketing of its products; market size and growth; the timing of FDA filings or approvals, including the DMF of ANP; the timing of product launches; acquisitions and other matters related to its pipeline of product candidates; its share buyback program and other future events, such as the impact of COVID-19 pandemic and related responses of business and governments to the pandemic on our operations and personnel and on our commercial activity and demand across our business operations and results of operations. These statements are not historical facts, but rather are based on Amphastar's historical performance and its current expectations, estimates and projections regarding Amphastar's business operations and other similar or related factors. Words such as may, might, will, could, would, should, anticipate, predict, potential, continue, expect, intend, plan, project, believe, estimate and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words.